EUVIMEDEUVIMED entdecken
Crossref

Insulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis

Reshma Reguram iD, Rushi Shah, Tanisha Vora, Camelia Arsene, Geetha Krishnamoorthy, Sudhanva Neti, Durga Yerasuri, F N U Manas, Wael Taha iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Reshma Reguram und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital, Pontiac, MI 48341, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Patient Readmission, Hospital Mortality. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Adults with type 1 diabetes (T1D) experience substantial inpatient morbidity, including frequent readmissions and measurable in-hospital mortality, contributing significantly to US health care utilization.

Objective

To evaluate the association between insulin delivery modality and 30-day readmission and in-hospital mortality among adults hospitalized with T1D. Design, setting, and participants Retrospective cohort study using the 2022 Nationwide Readmissions Database, a nationally representative all-payer inpatient database. Adults (≥18 years) hospitalized with T1D were identified using ICD-10-CM codes. Index admissions were defined as the first eligible hospitalization per patient within the calendar year; December and elective admissions were excluded to ensure complete 30-day follow-up. Exposure Insulin pump therapy (± injectable insulin) vs injectable insulin only. Main outcomes and measures Primary outcome was time to first all-cause readmission within 30 days. Secondary outcomes included in-hospital mortality during index admission and readmission. Survey-weighted Cox and logistic regression models estimated adjusted hazard ratios (aHRs) and odds ratios (aORs).

Results

The weighted cohort included 230 958 adult index admissions. Thirty-day readmission occurred in 14.64% of pump users vs 20.63% of injectable-only users. After multivariable adjustment, pump therapy was associated with lower readmission risk (aHR, 0.77; 95% CI, 0.74-0.81; P < .001). In secondary analyses, this association persisted for 90-day readmission outcomes. In-hospital mortality during index admission was lower among pump users (0.90% [95% CI, 0.78-1.05]) compared with injectable-only users (1.31% [95% CI, 1.21-1.42]). Pump therapy remained associated with reduced mortality (aOR, 0.78; 95% CI, 0.66-0.93; P = .006).

Conclusion

In this nationally representative cohort, insulin pump therapy was independently associated with lower 30-day readmission and in-hospital mortality among adults with T1D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsPatient ReadmissionHospital MortalityInsulinHypoglycemic AgentsHumansFemaleAdultRetrospective StudiesMaleMiddle AgedDatabases, FactualUnited StatesYoung AdultAdolescent

Stichwörter der Autor:innen

30-day readmissiondiabetes technologyhealth care utilizationin-hospital mortalityinsulin pump therapytype 1 diabetes mellitus

Substanzen

InsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Wayne State University and Trinity Health Oakland Hospital, Pontiac, MI 48341, USA.
  • Department of Biomedical Sciences, Wayne State University School of Medicine, Detroit, MI 48203, USA.
  • Department of Endocrinology, Trinity Health Livonia, Livonia, MI 48152, USA.
  • Department of Endocrinology, Trinity Health Endocrinology, Rochester Hills, MI 48309, USA.
  • Department of Endocrinology, Wayne State University, Detroit, MI 48201, USA.

ORCID-Profile: Reshma Reguram, Wael Taha

Zitieren

APA

Reguram, R., Shah, R., Vora, T., Arsene, C., Krishnamoorthy, G., Neti, S., Yerasuri, D., Manas, F. N. U., & Taha, W. (2026). Insulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag307

Vancouver

Reguram R, Shah R, Vora T, Arsene C, Krishnamoorthy G, Neti S, et al. Insulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag307

BibTeX
@article{Reguram2026,
  author = {Reguram, Reshma and Shah, Rushi and Vora, Tanisha and Arsene, Camelia and Krishnamoorthy, Geetha and Neti, Sudhanva and Yerasuri, Durga and Manas, F N U and Taha, Wael},
  title = {Insulin pump use and hospital outcomes in adults with type 1 diabetes: a 2022 Nationwide Readmissions Database analysis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag307}
}
Kostenlos starten →